Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Torrejon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advanced Biosystems|August 1, 2020
A Biomimetic, Stem Cell-Derived In Vitro Ocular Outflow ModelYangzi Isabel Tian, Xulang Zhang, Karen Torrejon, et al.
Acta Biomaterialia|January 27, 2020
A bioengineering approach to Schlemm's canal-like stem cell differentiation for in vitro glaucoma drug screeningYangzi Isabel Tian, Xulang Zhang, Karen Torrejon, et al.
Research Square|July 23, 2024
TRPV4 subserves physiological and pathological elevations in intraocular pressureSarah N Redmon, Monika Lakk, Yun-Ting Tseng, et al.
The Journal of Physiology|July 10, 2025
TRPV4 controls circadian and pathological ocular hypertensionSarah N Redmon, Monika Lakk, Yun-Ting Tseng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advanced Biosystems|August 1, 2020
A Biomimetic, Stem Cell-Derived In Vitro Ocular Outflow ModelYangzi Isabel Tian, Xulang Zhang, Karen Torrejon, et al.
Acta Biomaterialia|January 27, 2020
A bioengineering approach to Schlemm's canal-like stem cell differentiation for in vitro glaucoma drug screeningYangzi Isabel Tian, Xulang Zhang, Karen Torrejon, et al.
Research Square|July 23, 2024
TRPV4 subserves physiological and pathological elevations in intraocular pressureSarah N Redmon, Monika Lakk, Yun-Ting Tseng, et al.
The Journal of Physiology|July 10, 2025
TRPV4 controls circadian and pathological ocular hypertensionSarah N Redmon, Monika Lakk, Yun-Ting Tseng, et al.
Pageof 1